Lind Kevin Robert

Filings at 2 companies/Director · Avalo Therapeutics, Inc.

5 of 9 shown

The 5 most recent of 9 visible filings, newest first.

  • $16,616Grant
    TradedSep 30, 2026FiledOct 2, 2026
  • Apnimed, Inc. Chief executive officer
    108,916 sharesGrant
    TradedAug 3, 2026FiledAug 3, 2026
  • Apnimed, Inc. Chief executive officer
    108,916 sharesReturned to the issuer
    TradedAug 3, 2026FiledAug 3, 2026
  • Apnimed, Inc. Chief executive officer
    1,186,278 sharesGrant
    TradedAug 3, 2026FiledAug 3, 2026
  • Apnimed, Inc. Chief executive officer
    1,186,278 sharesReturned to the issuer
    TradedAug 3, 2026FiledAug 3, 2026